Company news
Assembly Biosciences, Inc. news in 2024
Assembly Biosciences, Inc.'s news releases, calls and decks from 2024, newest first.
Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B
December 25, 2024
Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs
December 18, 2024
Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates
November 6, 2024
Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366
September 22, 2024
Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates
August 7, 2024
Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop
July 14, 2024
Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus Infection
June 17, 2024
Assembly Biosciences Announces $12.6 Million in Equity Financings
June 16, 2024
Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366
June 9, 2024
Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024
June 4, 2024
Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024
May 21, 2024
Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
May 7, 2024
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
March 27, 2024
Assembly Biosciences Announces Effective Date of Reverse Stock Split
February 7, 2024
Assembly Biosciences Provides Anticipated Development Milestones for 2024
January 3, 2024